QScreen AI Announces $681,000 Debt Settlement with Directors and Officers
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability
QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware
QScreen AI Announces Adoption of Semi-Annual Reporting
QScreen AI Announces Close of First Tranche of Private Placement
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration
QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios
QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone - Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths
QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America
QScreen AI Advances Structured Commercial Discussions Following Canadian Trade Mission to Mexico
QScreen AI Advances Quantum-Inspired Optimization with U.S. Patent Filing; Gains National Spotlight on CBC
Qscreen AI Announces Strategic U.S. Engagement to Drive Innovation in Public Safety and Institutional Health
Predictmedix AI Rebrands as QScreen AI Inc., (QAI) Harnessing Quantum-AI Synergy for Health Screening
Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
Predictmedix AI Inc - 2025 Year End Corporate Update
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Predictmedix AI Announces Closing of $460,150 First Tranche
Predictmedix AI Announces Non-Brokered Private Placement
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.